Natera
Natera
Natera, Inc. was established in 2003 as Gene Security Network, LLC and later incorporated in Delaware in 2007. The company developed around advanced molecular biology, bioinformatics, and cell-free DNA testing, with the goal of using genetic information to improve disease detection, monitoring, and healthcare decision-making. Natera became particularly well known for applying non-invasive testing methods to women’s health before expanding its technology into oncology, organ transplantation, and rare-disease applications.
Today, Natera is a diagnostics company focused primarily on women’s health, oncology, and organ health. Its technology combines molecular assays, statistical analysis, bioinformatics software, and artificial intelligence to identify clinically important genetic and molecular information from blood and other biological samples. Major products include Panorama for non-invasive prenatal testing, Horizon carrier screening, Signatera for personalized cancer monitoring, and Prospera for transplant-related assessment. Natera operates CAP-accredited and CLIA-certified laboratories in Austin, Texas and San Carlos, California.
Natera remains an independent publicly traded company listed on Nasdaq under the ticker NTRA. An important headquarters correction is necessary for older pages. Current October 2026 SEC filings identify 13011 McCallen Pass, Building A, Suite 100, Austin, Texas 78753 as Natera’s principal executive office and mailing address. The company’s San Carlos, California facility remains important, but it should no longer be presented as the current corporate headquarters.
Natera, Inc.
13011 McCallen Pass
Building A, Suite 100
Austin, TX 78753
United States
This is Natera’s current principal executive-office address and is confirmed by the company’s October 2026 SEC filings.
13011 McCallen Pass, Building A, Suite 100
Austin, TX 78753
United States
Natera’s primary corporate administration and executive functions are associated with its Austin operations.
Natera, Inc.
13011 McCallen Pass
Building A, Suite 100
Austin, TX 78753
United States
Current SEC filings use the same Austin address for both Natera’s business and mailing address.
Natera, Inc.
201 Industrial Road
San Carlos, CA 94070
United States
Natera maintains a major California office and laboratory location in San Carlos. The company also identifies this address for certain privacy-related correspondence.
Older information may identify San Carlos, California as Natera’s headquarters because the company historically maintained major corporate operations there. Current SEC records identify Austin, Texas as the principal executive office, so California should now be described as an important office and laboratory location rather than the current headquarters.
650-249-9090
This is Natera’s main corporate number listed in current SEC records.
650-240-4429
Natera publishes this number for its human patient-support team during normal office hours.
13011 McCallen Pass, Building A, Suite 100, Austin, TX 78753, United States
13011 McCallen Pass, Building A, Suite 100, Austin, TX 78753, United States
investor@natera.com
This is Natera’s official Investor Relations email. Patient and billing questions should use the appropriate product-specific support channel.
Genetic testing, molecular diagnostics, oncology diagnostics, women’s health, organ health, and biotechnology.
2003
Natera began as Gene Security Network, LLC before later becoming Natera, Inc.
Nasdaq: NTRA
Natera’s common stock is publicly traded under the ticker NTRA.
Natera operates important laboratory and corporate facilities in Austin, Texas and San Carlos, California.
Patient and healthcare-professional phone support is generally available Monday through Friday, 7:00 a.m. to 7:00 p.m. Central Time, excluding holidays.
Investor Relations: https://investor.natera.com/
Careers: https://careers.natera.com/
Panorama is Natera’s non-invasive prenatal screening test designed to evaluate certain chromosomal conditions using cell-free DNA from a maternal blood sample. It is one of the company’s best-known women’s health products.
Horizon helps identify whether prospective or expecting parents carry genetic variants associated with inherited conditions. Results can help patients and healthcare professionals better understand reproductive risks.
Signatera is a personalized molecular residual disease and cancer-monitoring test. It uses tumor-specific information to identify circulating tumor DNA and can support recurrence monitoring and treatment assessment in eligible patients.
Prospera is designed to assess organ-transplant health through donor-derived cell-free DNA. It can help physicians monitor transplant recipients for potential signs of rejection or injury.
Natera provides cancer-related molecular testing and monitoring services through products such as Signatera and related oncology offerings. These services are intended to complement clinical decision-making and long-term disease monitoring.
The company’s women’s health portfolio includes prenatal screening, carrier screening, miscarriage-related testing, and other genetic tests intended to support reproductive and pregnancy-related care.
Natera develops non-invasive tests for kidney and other transplant-related monitoring, helping clinicians evaluate organ health without relying exclusively on invasive procedures.
Natera provides genetic testing services intended to help healthcare professionals investigate rare inherited disorders and complex genetic conditions.
Natera operates billing-support and financial-assistance programs for eligible patients. The company encourages patients with cost concerns to contact its billing teams before allowing financial concerns to interfere with testing.
650-249-9090
This is Natera’s verified main corporate telephone number listed in current SEC records.
650-249-9090
The same main company number is associated with Natera’s current principal executive office.
650-240-4429
This number connects patients with Natera’s human support team for general assistance during published office hours.
650-489-9050
Natera publishes this number for oncology-related patient and healthcare-professional support.
650-273-4468
This is Natera’s current published contact number for Organ Health support.
844-778-4700
Natera publishes this toll-free number for Women’s Health patient and provider support.
650-600-6707
This number is listed for patient and caregiver inquiries related to Natera’s Rare Disease services.
844-384-2996
Natera publishes this number for qualifying genetic-testing billing and financial-assistance questions.
877-628-7748
Natera publishes this number, also represented as 877-NAT-PRIV, for privacy-rights and personal-information requests.
For general patient help, call 650-240-4429 during Natera’s published support hours. Have the patient’s name, date of birth, ordering healthcare provider, test name, sample information if available, and any case or order number ready. If the question concerns a specific product, using the appropriate Oncology, Organ Health, Women’s Health, or Rare Disease number will usually provide more direct assistance.
Billing questions should generally go to 844-384-2996, while Signatera oncology patients can also use 650-489-9050 for relevant testing and billing questions. Patients should keep insurance information, Explanation of Benefits documents, Natera invoices, and prior correspondence available when discussing charges.
For corporate, shareholder, or investor matters, use Natera’s main corporate number or Investor Relations. The headquarters switchboard is not the best first route for test-status or patient-billing questions because those services have dedicated support teams.
Complaints may involve billing, insurance processing, test delays, customer service, privacy, specimen handling, portal access, test results, or communication with healthcare providers. Before escalating, gather the test name, order information, invoices, insurance records, screenshots, emails, dates of contact, and any case numbers.
Begin with the Natera support team responsible for your test. Explain the issue clearly and request that the concern be documented. Keep the case number and the representative’s name when available.
Billing issues should go to billing support, while oncology, women’s health, organ health, rare-disease, and privacy matters should be routed to the specialized team responsible for that area.
If the first representative cannot resolve the concern, ask for a supervisor or senior representative. Explain what has already been attempted and what outcome you are requesting.
Submit the issue through Natera’s appropriate written or online support process. Include test identifiers, dates, bills, insurance information, and supporting documentation so the complaint can be reviewed efficiently.
Serious unresolved issues may be escalated to Natera, Inc., 13011 McCallen Pass, Building A, Suite 100, Austin, TX 78753. Clearly identify the department or type of complaint.
Privacy concerns can be directed to Natera’s Chief Privacy Officer using privacyofficer@natera.com or the dedicated privacy telephone number. Billing, medical-testing, and laboratory concerns should use the specialized channels applicable to those issues.
Depending on the complaint, regulatory options may include state health departments, laboratory regulators, the Centers for Medicare & Medicaid Services for qualifying laboratory issues, privacy authorities, or other healthcare regulators.
Billing or payment complaints may also be reported to a state attorney general, consumer-protection agency, insurer, or healthcare advocate after Natera has been given an opportunity to correct the issue.
For serious disputes involving privacy, billing, alleged laboratory errors, financial harm, or other legal rights, preserve all documentation and review applicable agreements and law before considering arbitration, litigation, or professional legal advice.
Ramona Tire is an automotive service company that provides a wide range of tire and…
Car-X Tire & Auto is a well-known automotive service chain in the United States, specializing…
Curo Financial Technologies Corp. is a company that provides a range of financial services, primarily…
Enova International, Inc. is a financial technology (fintech) company that provides online financial services to…
Community Choice Financial Inc. (CCFI) is a financial services company that provides a variety of…
Smile Brands Inc. is a leading provider of business support services to dental practices in…
This website uses cookies.